Legal Representation
Attorney
Bret E. Field
USPTO Deadlines
Application History
41 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 10, 2017 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Apr 10, 2017 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jan 9, 2017 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Sep 8, 2016 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 7, 2016 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Sep 2, 2016 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Sep 2, 2016 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 8, 2016 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 7, 2016 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Feb 29, 2016 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Feb 29, 2016 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 29, 2016 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 20, 2015 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 19, 2015 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Aug 13, 2015 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Aug 13, 2015 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 10, 2015 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 9, 2015 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Feb 26, 2015 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Apr 2, 2015 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Feb 26, 2015 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 16, 2014 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 14, 2014 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Aug 14, 2014 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Aug 14, 2014 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 8, 2014 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 4, 2014 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 7, 2014 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 7, 2014 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 18, 2013 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 3, 2013 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Nov 26, 2013 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Nov 25, 2013 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 25, 2013 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Nov 25, 2013 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Nov 25, 2013 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Nov 25, 2013 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Nov 23, 2013 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 21, 2013 | MPMK | E | NOTICE OF PSEUDO MARK E-MAILED | Loading... |
| Aug 20, 2013 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 13, 2013 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 003
Cosmetics; cosmetic preparations; adhesives for cosmetic purposes; cosmetic masks; soaps for personal use; perfumery; essential oils; hair lotions
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
Pharmaceuticals for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; pharmaceutical preparations, compositions, creams and lotions for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; prescription and over-the-counter pharmaceutical preparations for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; prescription and over-the-counter pharmaceutical preparations, namely, transdermal gel formulations, transdermal cream formulations, oral mucous formulations, transdermal patches, dressings and medical adhesive tapes for use in the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; pharmaceutical products, namely, analgesics
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Pharmaceutical research and development; pharmaceutical product evaluation, testing and inspection services; providing medical and scientific research information in the field of pharmaceuticals; information, advisory and consultancy services relating to all the aforesaid services
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
TEILOKI PHARMACEUTICAL USA PHARMACEUTICAL
Classification
International Classes
003
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMA"